Search research articles
Contact Us
Filters
Showing results (331-340 of 361) with videos related to
Page
of 37
Sort By:
Blood
|
September 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Adam D Cohen, María-Victoria Mateos, Yael C Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Molecular Cytogenetics
|
April 4, 2013
Heteromorphic variants of chromosome 9
Nadezda Kosyakova, Ani Grigorian, Thomas Liehr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2017
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Melissa Alsina, et al.
Journal of Medical Genetics
|
September 29, 2011
Phenotypic spectrum associated with CASK loss-of-function mutations
Ute Moog, Kerstin Kutsche, Fanny Kortüm, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Shaji K Kumar, Natalie S Callander, Jens Hillengass, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
Shaji K Kumar, Natalie S Callander, Melissa Alsina, et al.
Page
of 37
Search research articles
Search
Showing results (331-340 of 361) with videos related to
Sort By:
Page
of 37
Blood
|
September 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents
Adam D Cohen, María-Victoria Mateos, Yael C Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Molecular Cytogenetics
|
April 4, 2013
Heteromorphic variants of chromosome 9
Nadezda Kosyakova, Ani Grigorian, Thomas Liehr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 12, 2017
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Melissa Alsina, et al.
Journal of Medical Genetics
|
September 29, 2011
Phenotypic spectrum associated with CASK loss-of-function mutations
Ute Moog, Kerstin Kutsche, Fanny Kortüm, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2019
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Shaji K Kumar, Natalie S Callander, Jens Hillengass, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 4, 2018
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018
Shaji K Kumar, Natalie S Callander, Melissa Alsina, et al.
Page
of 37